The Selective ATR Inhibitor VX-970 Enhances the Therapeutic Effects of Radiation Therapy in Triple Negative Breast Cancer Patient-Derived Xenografts and is a Novel Strategy to Overcome Therapeutic Resistance

• DOI: 10.1016/j.ijrobp.2017.06.2072
• Publication Date: 2017-09-23T03:24:25Z
• Authors: R.W. Mutter; X. Tu; M.M. Kahila; X. Yu; M. Schroeder; B. Carlson; L. Wang; J.C. Boughey; M. Goetz; J.N. Sarkaria; Z. Lou
• Keywords: Triple-negative breast cancer; Neoadjuvant Therapy